About Company

Biocon is a global, innovation-led Indian biopharmaceutical company founded in 1978 by Kiran Mazumdar-Shaw, focused on developing and providing affordable medicines for diabetes, cancer, and autoimmune diseases. The company's activities span drug discovery, development, and manufacturing of generic active pharmaceutical ingredients (APIs), biosimilars, and novel biologics. With a presence in over 120 countries, Biocon aims to improve patient outcomes by enhancing access to complex and life-saving therapies.